chr4-88265027-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_152542.5(PPM1K):c.961G>A(p.Glu321Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0017 in 1,614,096 control chromosomes in the GnomAD database, including 41 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0088 ( 21 hom., cov: 33)
Exomes 𝑓: 0.00096 ( 20 hom. )
Consequence
PPM1K
NM_152542.5 missense
NM_152542.5 missense
Scores
1
5
9
Clinical Significance
Conservation
PhyloP100: 5.96
Genes affected
PPM1K (HGNC:25415): (protein phosphatase, Mg2+/Mn2+ dependent 1K) This gene encodes a member of the PPM family of Mn2+/Mg2+-dependent protein phosphatases. The encoded protein, essential for cell survival and development, is targeted to the mitochondria where it plays a key role in regulation of the mitochondrial permeability transition pore. [provided by RefSeq, Sep 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.00920701).
BP6
Variant 4-88265027-C-T is Benign according to our data. Variant chr4-88265027-C-T is described in ClinVar as [Benign]. Clinvar id is 775998.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00878 (1336/152216) while in subpopulation AFR AF= 0.0298 (1238/41528). AF 95% confidence interval is 0.0284. There are 21 homozygotes in gnomad4. There are 622 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 21 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPM1K | ENST00000608933.6 | c.961G>A | p.Glu321Lys | missense_variant | 6/7 | 1 | NM_152542.5 | ENSP00000477341.1 | ||
PPM1K | ENST00000508256.5 | c.304G>A | p.Glu102Lys | missense_variant | 5/6 | 2 | ENSP00000476452.1 | |||
PPM1K | ENST00000295908.11 | c.853-2301G>A | intron_variant | 5 | ENSP00000295908.7 |
Frequencies
GnomAD3 genomes AF: 0.00878 AC: 1335AN: 152098Hom.: 21 Cov.: 33
GnomAD3 genomes
AF:
AC:
1335
AN:
152098
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00238 AC: 598AN: 251408Hom.: 12 AF XY: 0.00154 AC XY: 209AN XY: 135884
GnomAD3 exomes
AF:
AC:
598
AN:
251408
Hom.:
AF XY:
AC XY:
209
AN XY:
135884
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000960 AC: 1403AN: 1461880Hom.: 20 Cov.: 31 AF XY: 0.000807 AC XY: 587AN XY: 727242
GnomAD4 exome
AF:
AC:
1403
AN:
1461880
Hom.:
Cov.:
31
AF XY:
AC XY:
587
AN XY:
727242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00878 AC: 1336AN: 152216Hom.: 21 Cov.: 33 AF XY: 0.00836 AC XY: 622AN XY: 74430
GnomAD4 genome
AF:
AC:
1336
AN:
152216
Hom.:
Cov.:
33
AF XY:
AC XY:
622
AN XY:
74430
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
137
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
344
Asia WGS
AF:
AC:
8
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Maple syrup urine disease, mild variant Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
PrimateAI
Uncertain
T
Sift4G
Benign
T;T
Polyphen
P;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at